- Bendamustine HCL 100mg Injection
Bendamustine HCL Injection is alkylating agent indicated against protection from following side effects:
- Chronic lymphocytic leukemia
- Indolent B-cell non-Hodgkin lymphoma that developed during or within treatment with rituximab or rituximab containing regimen
- Non-Hodgkin’s lymphoma
Information for patients:
Inform your doctor in advance if you have diabetes, liver, renal, or if you use any medications to treat infections. Let your doctor know about all of the medications you are taking since many other medications can interact with this one or be impacted by it.
healthcare best health related products provider